Navigation Links
Funds Boost Research into Causes, Interventions for Age-Related Cognitive Decline
Date:3/1/2010

the NIA and the MBRF, aimed at studying interventions to remediate age-related cognitive decline and neural and behavioral profiles of cognitive function in aging. Grantees and study topics are:

Ellen F. Binder, M.D., and Mark A. McDaniel, Ph.D., Washington University School of Medicine, St. Louis: Combining Exercise and Cognitive Training to Improve Everyday Function

Patricia A. Boyle, Ph.D., Rush University Medical Center, Chicago: Characterizing the Behavior Profile of Healthy Cognitive Aging

Randy L. Buckner, Ph.D., Massachusetts General Hospital, Boston: Neural Processes Underlying Cognitive Aging

Jeffrey M. Burns, M.D., University of Kansas Medical Center, Kansas City: Dose-Response Study of Exercise in Older Adults


'/>"/>
SOURCE National Institutes of Health
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. NIH Funds Vaccine Research for Needle-free and Self-Administered Protection Against Pandemic Influenza
2. NSF Funds New Entrepreneurship Program
3. Notice of Initial Distribution of Net Settlement Funds
4. NIH Funds $1M Research at Quest Product Development and University of Colorado for New Digitally-Controlled Endoscopes
5. Hoana Medical and Hawaii Union Health and Welfare Trust Funds Partner to Fix Healthcare
6. LI-COR Biosciences Offers $1.75 Million in Matching Funds for Undergraduate Genomics Education
7. Immune Targeting Systems Completes Second Tranche of Series-A Funding Bringing Total Funds Raised to More Than GBP5m
8. Obama Budget Level Funds Career Technical Education
9. Printing New Organs: Foundation Funds Medical Technology That Replicates Human Tissue
10. NeoStem Raises Additional Funds from Principals of Suzhou Erye Pharmaceuticals Company Ltd. and U.S. Institutional and Private Investors, Bringing the Total Recent Financings to Over $15 Million; Funds Will Support Expansion Activities in the United State
11. NIH funds support UAB joint replacement research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... 2015 , ... Rainbow Scientific, Inc. (RSI), a North American ... BI’s line of human mesenchymal stem cell (hMSC) differentiation media, MSC go ... complete system for multipotency evaluation of hMSCs and reliable induction of hMSCs into ...
(Date:7/28/2015)... July 29, 2015 A ... acquiring, rapidly developing and commercialising innovative medicines to ... Highly experienced management team; blue chip ...   Mereo BioPharma Group Ltd ("Mereo"), a recently-formed ... ( c. £76.5m), gross, from blue chip institutional investors ...
(Date:7/28/2015)... , July 28, 2015  PDL BioPharma, Inc. ... announced that the Company will release its second quarter ... 2015, on Wednesday, August 5, 2015, after market close. ... that day at 4:30 p.m. Eastern Time to discuss ... call will be available via the webcast link on ...
(Date:7/28/2015)... , ... July 28, 2015 , ... ... than EUR 1.022 billion in 2013; while production volume reached close to 1.84 ... producing country with a share of 75.5% of the region’s total aluminium hydroxide ...
Breaking Biology Technology:Rainbow Scientific, Inc. Announces Availability of Human Mesenchymal Stem Cell Differentiation Media 2Rainbow Scientific, Inc. Announces Availability of Human Mesenchymal Stem Cell Differentiation Media 3Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 2Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 3Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 4Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 5Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 6Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 7Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 8Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 9Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 10Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 11PDL BioPharma to Announce Second Quarter 2015 Financial Results on August 5, 2015 2EU27 Aluminium Hydroxide Market Analysed and Forecast by BAC Reports in New Research Study Available at MarketPublishers.com 2EU27 Aluminium Hydroxide Market Analysed and Forecast by BAC Reports in New Research Study Available at MarketPublishers.com 3
... Advice Shared Through Dynamic WikiAnswers Q&A ... ... a show of support for National,Breast Cancer Awareness Month, Answers.com,s question ... ), where breast cancer survivors,friends and family have gathered to ask ...
... Win Needed Medical ... Oct. 22 Television medical dramas such as,ER and House ... country to millions of Americans each week. Now, small hospitals,lacking ... - are being given the opportunity to turn the cameras ...
... 22 Genzyme Corp.,(Nasdaq: GENZ ) today ... granted marketing approval for Renvela(TM) (sevelamer carbonate) for,the ... kidney disease on,dialysis. Renvela is a next-generation version ... the United States. "Since its approval in ...
Cached Biology Technology:Answers.com's WikiAnswers Supervisors Rallying for National Breast Cancer Awareness Month 2Answers.com's WikiAnswers Supervisors Rallying for National Breast Cancer Awareness Month 3American M.R.I.-DOL: Small Hospitals To Turn The Camera On Themselves In Unique National Contest 2American M.R.I.-DOL: Small Hospitals To Turn The Camera On Themselves In Unique National Contest 3FDA Approves Genzyme's Renvela(TM) for Dialysis Patients 2FDA Approves Genzyme's Renvela(TM) for Dialysis Patients 3FDA Approves Genzyme's Renvela(TM) for Dialysis Patients 4FDA Approves Genzyme's Renvela(TM) for Dialysis Patients 5
(Date:7/2/2015)... , June 25, 2015 ... the addition of the "Natural Language Processing ... (Recognition, IVR, OCR, Pattern & Image Recognition) - ... offering. The key vendors occupying the ... IBM Corporation, Microsoft Corporation, NetBase Solutions, SAS Institute ...
(Date:6/30/2015)... , June 30, 2015 Genisphere ... company as CEO to help further develop Genisphere,s therapeutics ... of partnering experience, having spent much of the last ... Therakine, Amgen, Baxter Bioscience, and Johnson & Johnson. Tom ... on Technology and Biotech Corporate Finance. He graduated from ...
(Date:6/25/2015)... CITY , June 25, 2015  Imagine a ... steps toward a healthier, happier life. That,s exactly what ... designed to do. The cutting-edge, portable health program provides ... real-life solutions to help improve your lifestyle and nutrition. ... awards dinner and gala Wednesday night, USANA,s THA was ...
Breaking Biology News(10 mins):Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2
... cells communicate with each other and how to enhance ... promising work by a Kansas State University researcher. ... of diagnostic medicine and pathobiology at K-State,s College of ... National Institutes of Health to continue her cancer research. ...
... postmenopausal hormone therapy for more than 15 years increases ... leaner women according to research at the Keck School ... An analysis of the California Teachers Study focused ... women for nearly 10 years. The research was conducted ...
... Georgia Institute of Technology have attained very promising results on ... Using a new technique involving mass spectrometry of a single ... ovarian cancer in 100 percent of the patients tested. The ... Epidemiology, Biomarkers, & Prevention Research . "Because ovarian ...
Cached Biology News:K-State professor's cancer research gets boost from National Institutes of Health 2K-State professor's cancer research gets boost from National Institutes of Health 3Cancer risk found for long-term hormone therapy 2Initial trials on new ovarian cancer tests exhibit extremely high accuracy 2
... ReadyPrep 2-D starter kit is intended for first-time ... IPG strips. The kit includes a protein sample ... to second-dimension gels six 17 cm, ten 11 ... (ReadyStrip IPG strips and precast SDS-PAGE gels and ...
... Phosphate Phosphatase 2 (LPP2) ... aqueous solution Solution ... containing 0.08% sodium azide. ... the human LPP2 protein. ...
... Phospho-Specific(Thr 222 ) ... 10 mM sodium HEPES, 100 ... 7.5. Recognizes the ~47 kDa ... (MAPKAPK-2) protein phosphorylated at Thr ...
Rabbit polyclonal to SMURF 2 ( Abpromise for all tested applications). Antigen: A KLH conjugated synthetic peptide (10-30 aa in length) at the N-term of first 50 aa of human SMURF 2. Entrez G...
Biology Products: